| Acod1 | Aconitate decarboxylase 1 |
| AMPK | AMP-activated protein kinase |
| CD | Context-specific direct support |
| DED | Dry eye disease |
| DR | Diabetic retinopathy |
| EAU | Experimental autoimmune uveitis |
| EIU | Endotoxin-induced uveitis |
| EV | Extracellular vesicle |
| Fc | Fragment crystallizable |
| GalNAc | N-acetylgalactosamine |
| GRADE | Grading of Recommendations Assessment, Development, and Evaluation |
| HAM | Hepatic animal-model evidence |
| HO | Hypothesis only (claim-support category) |
| HY | Hypothesis only (intervention-development category) |
| LI | Limited or indirect support |
| MASLD | Metabolic dysfunction-associated steatotic liver disease |
| MASH | Metabolic dysfunction-associated steatohepatitis |
| MetALD | Metabolic dysfunction and alcohol-associated liver disease |
| NET | Neutrophil extracellular trap |
| NHC | Non-ophthalmic human clinical exposure |
| OAM | Ocular animal-model evidence |
| OCC | Ocular cell-culture evidence |
| PC | Platform concept |
| PP2A | Protein phosphatase 2A |
| RAGE | Receptor for advanced glycation end products |
| S100A9 | S100 calcium-binding protein A9 |
| SANRA | Scale for the Assessment of Narrative Review Articles |
| siRNA | Small interfering RNA |
| STAT3 | Signal transducer and activator of transcription 3 |
| Th17 | T helper 17 |
| TLR4 | Toll-like receptor 4 |